Vixiar Medical, a spin-off from Johns Hopkins, recently completely its seed round funding. The USD $1.5million investment was provided by the Abell Foundation and TEDCO, as well as Kacero Holdings, a Chinese medical device and services investment firm. It will be used to expand its R&D effort.
Vixiar’s product, called Indicor, is a handheld device and corresponding Android app that helps patients monitor worsening heart failure. The device is non-invasive, and measures cardiac filling pressure. It was designed to be utilized in a variety of settings, including those outside the clinic.
About China Med Device, LLC (CMD) CMD provides turn-key solution for Western medtech companies with regulatory and commercialization services. CMD helps its clients accelerate China entry and growth by offering: market Intelligence and research; CFDA regulatory services (premarket submission, clinical evaluation, clinical trial design & management, post market compliance and legal representation), and other commercial services. If you have an inquiry or feedback regarding our services please email us at info@ChinaMedDevice.com.